Literature DB >> 9405946

Longitudinal study of Aspergillus fumigatus strains isolated from cystic fibrosis patients.

C Neuvéglise1, J Sarfati, J P Debeaupuis, H Vu Thien, J Just, G Tournier, J P Latgé.   

Abstract

The colonization over time of cystic fibrosis patients by Aspergillus fumigatus was investigated using a DNA fingerprinting method. Aspergillus fumigatus isolates collected sequentially for more than one year from six patients with cystic fibrosis were typed by Southern blot hybridization with a repetitive DNA sequence. Each cystic fibrosis patient harbored several strains of Aspergillus fumigatus that were isolated recurrently over time. Isolates collected from a cystic fibrosis patient with aspergilloma displayed the same genotype, suggesting that the infection was due to a single strain. Continuous isolation of the same genotype in another cystic fibrosis patient, however, was not correlated clinically with an Aspergillus infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405946     DOI: 10.1007/bf01709257

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  A P Knutsen; R G Slavin
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis.

Authors:  P E Verweij; J F Meis; J Sarfati; J A Hoogkamp-Korstanje; J P Latgé; W J Melchers
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis.

Authors:  C Wojnarowski; I Eichler; C Gartner; M Götz; S Renner; D Y Koller; T Frischer
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

4.  Afut1, a retrotransposon-like element from Aspergillus fumigatus.

Authors:  C Neuveglise; J Sarfati; J P Latge; S Paris
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

5.  Development of DNA probes for fingerprinting Aspergillus fumigatus.

Authors:  H Girardin; J P Latgé; T Srikantha; B Morrow; D R Soll
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus.

Authors:  J P Debeaupuis; J Sarfati; V Chazalet; J P Latgé
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  S Mroueh; A Spock
Journal:  Chest       Date:  1994-01       Impact factor: 9.410

8.  Allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  P Laufer; J N Fink; W T Bruns; G F Unger; J H Kalbfleisch; P A Greenberger; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1984-01       Impact factor: 10.793

9.  Clinical and serological survey of pulmonary aspergillosis in patients with cystic fibrosis.

Authors:  H Schønheyder; T Jensen; N Høiby; C Koch
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

10.  Immune responses to Aspergillus in cystic fibrosis.

Authors:  R Zeaske; W T Bruns; J N Fink; P A Greenberger; H Colby; J L Liotta; M Roberts
Journal:  J Allergy Clin Immunol       Date:  1988-07       Impact factor: 10.793

View more
  14 in total

1.  Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.

Authors:  M Noni; A Katelari; G Dimopoulos; S-E Doudounakis; C Tzoumaka-Bakoula; V Spoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-30       Impact factor: 3.267

2.  High-resolution genotyping of Aspergillus fumigatus isolates recovered from chronically colonised patients with cystic fibrosis.

Authors:  L M E Vanhee; F Symoens; J-P Bouchara; H J Nelis; T Coenye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-06       Impact factor: 3.267

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis.

Authors:  Alain Defontaine; Rachid Zouhair; Bernard Cimon; Jacqueline Carrère; Eric Bailly; Françoise Symoens; Mohammed Diouri; Jean-Noel Hallet; Jean-Philippe Bouchara
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease.

Authors:  E C Williamson; D Speers; I H Arthur; G Harnett; G Ryan; T J Inglis
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 7.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

8.  Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Authors:  V Chazalet; J P Debeaupuis; J Sarfati; J Lortholary; P Ribaud; P Shah; M Cornet; H Vu Thien; E Gluckman; G Brücker; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Authors:  J Houbraken; S Giraud; M Meijer; S Bertout; J C Frisvad; J F Meis; J P Bouchara; R A Samson
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

10.  Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.

Authors:  David A Stevens; Richard B Moss; Cathy Hernandez; Karl V Clemons; Marife Martinez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.